Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in SunOpta Inc. (NASDAQ:STKL - Free Report) TSE: SOY during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 523,000 shares of the company's stock, valued at approximately $4,027,000. Universal Beteiligungs und Servicegesellschaft mbH owned approximately 0.44% of SunOpta at the end of the most recent quarter.
A number of other large investors also recently added to or reduced their stakes in the business. PharVision Advisers LLC purchased a new position in SunOpta in the 4th quarter worth approximately $153,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in SunOpta by 4.7% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 91,055 shares of the company's stock worth $701,000 after purchasing an additional 4,053 shares in the last quarter. Woodline Partners LP lifted its holdings in SunOpta by 26.2% in the 4th quarter. Woodline Partners LP now owns 1,541,019 shares of the company's stock worth $11,866,000 after purchasing an additional 320,284 shares in the last quarter. Two Sigma Investments LP lifted its holdings in SunOpta by 53.0% in the 4th quarter. Two Sigma Investments LP now owns 56,428 shares of the company's stock worth $434,000 after purchasing an additional 19,551 shares in the last quarter. Finally, Teza Capital Management LLC bought a new stake in SunOpta in the 4th quarter worth approximately $201,000. 85.39% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In other SunOpta news, SVP Bryan P. Clark sold 8,500 shares of the company's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $5.32, for a total value of $45,220.00. Following the transaction, the senior vice president now owns 28,150 shares of the company's stock, valued at $149,758. This represents a 23.19% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Corporate insiders own 1.90% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen raised SunOpta from a "sell" rating to a "hold" rating in a research note on Tuesday, March 11th.
Read Our Latest Analysis on SunOpta
SunOpta Price Performance
NASDAQ:STKL traded down $0.02 during trading hours on Thursday, reaching $5.74. The stock had a trading volume of 3,674,719 shares, compared to its average volume of 776,045. The company has a debt-to-equity ratio of 1.61, a quick ratio of 0.53 and a current ratio of 1.20. SunOpta Inc. has a 52 week low of $3.65 and a 52 week high of $8.11. The company has a 50 day moving average price of $4.96 and a two-hundred day moving average price of $6.35. The stock has a market capitalization of $674.69 million, a PE ratio of -31.89 and a beta of 1.50.
SunOpta (NASDAQ:STKL - Get Free Report) TSE: SOY last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.04 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.02 by $0.02. SunOpta had a positive return on equity of 7.92% and a negative net margin of 2.74%. The business had revenue of $201.63 million for the quarter, compared to the consensus estimate of $195.09 million. As a group, sell-side analysts anticipate that SunOpta Inc. will post 0.13 earnings per share for the current fiscal year.
About SunOpta
(
Free Report)
SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.
Featured Stories

Before you consider SunOpta, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SunOpta wasn't on the list.
While SunOpta currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.